In Vivo Delivery of Adenoviral Vector Containing Interleukin-17 Receptor A Reduces Cardiac Remodeling and Improves Myocardial Function in Viral Myocarditis Leading to Dilated Cardiomyopathy

Th17 cells have been implicated in the pathogenesis of myocarditis. Interleukin (IL)-17A produced by Th17 cells is dispensable for viral myocarditis but essential for the progression to dilated cardiomyopathy (DCM). This study investigated whether the adenoviral transfer of the IL-17 receptor A reduces myocardial remodeling and dysfunction in viral myocarditis leading to DCM. In a mouse model of Coxsackievirus B3 (CVB3)-induced chronic myocarditis, the delivery of the adenovirus-containing IL-17 receptor A (Ad-IL17RA:Fc) reduced IL-17A production and decreased the number of Th17 cells in the spleen and heart, leading to the down-regulation of systemic TNF-α and IL-6 production. Cardiac function improved significantly in the Ad-IL17R:Fc- compared with the Ad-null-treated mice 3 months after the first CVB3 infection. Ad-IL17R:Fc reduced the left ventricle dilation and decreased the mortality in viral myocarditis, leading to DCM (56% in the Ad-IL17R:Fc versus 76% in the Ad-null group). The protective effects of Ad-IL17R-Fc on remodeling correlated with the attenuation of myocardial collagen deposition and the reduction of fibroblasts in CVB3-infected hearts, which was accompanied by the down-regulation of A distintegrin and metalloprotease with thrombospondin type 1 motifs (ADAMTS-1), Matrix metalloproteinase-2(MMP-2), and collagen subtypes I and III in the heart. Moreover, in cultured cardiac fibroblasts, IL-17A induced the expression of ADAMTS-1, MMP-2, and collagen subtypes I and III and increased the proliferation of fibroblasts. We determined that the delivery of IL-17-RA:Fc reduces cardiac remodeling, improves function, and decreases mortality in viral myocarditis leading to DCM, possibly by suppressing fibrosis. Therefore, the adenoviral transfer of the IL-17 receptor A may represent an alternative therapy for chronic viral myocarditis and its progression to DCM.

[1]  Y. Chu,et al.  Critical role of interleukin‐17/interleukin‐17 receptor axis in mediating Con A‐induced hepatitis , 2012, Immunology and cell biology.

[2]  Sandeep Sagar,et al.  Myocarditis , 2012, The Lancet.

[3]  J. Ge,et al.  The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. , 2011, Virology.

[4]  J. Ge,et al.  Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. , 2011, European journal of pharmacology.

[5]  L. Sorokin.  The impact of the extracellular matrix on inflammation , 2010, Nature Reviews Immunology.

[6]  K. Ley,et al.  Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice , 2010, Circulation.

[7]  Y. Iwakura,et al.  Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy , 2010, Circulation research.

[8]  Wei Liu,et al.  IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. , 2009, Experimental and molecular pathology.

[9]  D. Gardner,et al.  Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. , 2009, Cardiovascular research.

[10]  L. Fouser,et al.  Th17 cytokines and their emerging roles in inflammation and autoimmunity , 2008, Immunological reviews.

[11]  U. Eriksson,et al.  CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis1 , 2008, The Journal of Immunology.

[12]  N. Rose,et al.  Pathogenesis of myocarditis and dilated cardiomyopathy. , 2008, Advances in immunology.

[13]  D. Littman,et al.  Transcriptional regulation of Th17 cell differentiation. , 2007, Seminars in immunology.

[14]  Yong Yu,et al.  [Association between myocardial ADAMTS-1 expression and myocardial fibrosis in a murine model of viral myocarditis]. , 2007, Zhonghua xin xue guan bing za zhi.

[15]  Christopher R. Ellis,et al.  Myocarditis: Basic and Clinical Aspects , 2007, Cardiology in review.

[16]  V. Kuchroo,et al.  TH-17 cells in the circle of immunity and autoimmunity , 2007, Nature Immunology.

[17]  M. Kurrer,et al.  Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis , 2006, European journal of immunology.

[18]  J. Kolls,et al.  Critical role of IL‐17 receptor signaling in acute TNBS‐induced colitis , 2006, Inflammatory bowel diseases.

[19]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[20]  Ying-zhen Yang,et al.  Microarray analysis of extracellular matrix genes expression in myocardium of mouse with Coxsackie virus B3 myocarditis. , 2004, Chinese medical journal.

[21]  M. Iruela-Arispe,et al.  ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165* , 2003, Journal of Biological Chemistry.

[22]  S. Marsch,et al.  Interleukin-6–Deficient Mice Resist Development of Autoimmune Myocarditis Associated With Impaired Upregulation of Complement C3 , 2003, Circulation.

[23]  S. Huber,et al.  Vγ4+ T Cells Promote Autoimmune CD8+ Cytolytic T-Lymphocyte Activation in Coxsackievirus B3-Induced Myocarditis in Mice: Role for CD4+ Th1 Cells , 2002, Journal of Virology.

[24]  A. Feldman,et al.  MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. , 2002, American journal of physiology. Heart and circulatory physiology.

[25]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[26]  K. Matsushima,et al.  ADAMTS‐1 cleaves a cartilage proteoglycan, aggrecan , 2000, FEBS letters.

[27]  J. Whitton,et al.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis , 1995, Journal of virology.